No Data
No Data
tianjin motimo membrane technology (300334.SZ) plans to publicly list and sell 40% equity of Tianjun Wealthy for the proceeds to supplement liquidity.
tianjin motimo membrane technology (300334.SZ) announced that the company plans to transfer its holdings of the alliance publicly and listed.
Tianjin Motimo Membrane Technology (300334.SZ): The controlling shareholder is planning to invest 30 million yuan to establish a membrane material innovation fund.
November 7th news from Gelunhui: Tianjin Motimo Membrane Technology (300334.SZ) announced that the company recently received a written notice from the controlling shareholder Hangmo Technology Development Group Co., Ltd., Hangmo Group plans to jointly invest with Hebei Science and Technology Financial Development Promotion Center, Cangzhou City Emerging Industry Development Fund (Limited Partnership), Cangzhou High-tech Zone Chufu Industrial Development Co., Ltd., and other local state-owned funds, state-owned investment platform units, and other contributing units to jointly establish the Cangzhou Membrane Material Technology Entrepreneurship Investment Fund (tentatively named, hereinafter referred to as the "Membrane Material Sci-Tech Fund" or "Fund"), with a total fund size of 0.3 billion yuan, of which Hangmo Group plans to subscribe 300 million yuan.
Tianjin Membrane Technology: Report for the third quarter of 2024
tianjin motimo membrane technology (300334.SZ) announced its performance for the first three quarters, with a net loss of 11.8837 million yuan.
Tianjin Motimo Membrane Technology (300334.SZ) released the third quarter report for 2024, with revenue for the first three quarters reaching ...
Tianjin MOTIMO Membrane Technology Co.,Ltd (SZSE:300334) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Tianjin Motimo Membrane Technology (300334.SZ): No detailed planning has been done for the African market.
Tianjin Motimo Membrane Technology (300334.SZ) stated in an investor relations activity that the main target markets for the company's membrane products are Europe, America, the Middle East, and Southeast Asia. Detailed planning has not been made for the African market. The company will continue to monitor the African market and adjust sales channels and resources according to market demand.